U.S. Markets open in 4 hrs 30 mins

Chimerix, Inc. (CMRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.63-0.09 (-1.91%)
At close: 4:00PM EDT
People also watch
Interactive chart
Previous Close4.72
Bid3.15 x 100
Ask8.88 x 100
Day's Range4.61 - 4.76
52 Week Range3.50 - 6.64
Avg. Volume369,869
Market Cap216M
PE Ratio (TTM)-3.16
EPS (TTM)-1.46
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.57
Trade prices are not sourced from all markets
  • American City Business Journals15 days ago

    Chimerix outlines plans for DNA virus drug

    Chimerix executives outlined plans for the company’s DNA virus drug and lead product candidate brincidofovir on its first quarter results call Tuesday. The company is continuing to progress a new intravenous formulation of brincidofovir after halting two trials for the drug early last year and cutting 20 percent of its workforce . “In 2018 we plan to have two pivotal trials for brinci - one in short-course oral brinci and one in IV brinci.

  • Associated Press16 days ago

    Chimerix reports 1Q loss

    The Durham, North Carolina-based company said it had a loss of 38 cents per share. The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...

  • Accesswire16 days ago

    Investor Network: Chimerix, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Chimerix, Inc. (NASDAQ: CMRX ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 8:30 AM Eastern Time. To listen to ...